ARKA Clinical Decision Support is designed to meet all four criteria for Non-Device CDS under FD&C Act §520(o)(1)(E) and FDA's January 2026 final guidance on Clinical Decision Support Software. Recommendations support, not replace, the clinician's judgment. Every recommendation is anchored in a published guideline or peer-reviewed source, with the basis available for independent review. CLIN emphasizes imaging appropriateness at order entry.
This recommendation is intended to support, not replace, clinical judgment. It is generated by ARKA, software designed to meet the four criteria for Non-Device Clinical Decision Support under FD&C Act §520(o)(1)(E) and FDA's final guidance on Clinical Decision Support Software (January 2026). The clinician is responsible for the final decision.
AIIE Evidence
Do not routinely re-image typical breakthrough seizures with return to baseline; image for new deficits, trauma, or changed semiology.
A typical breakthrough seizure in a patient with established epilepsy who returns to baseline rarely requires emergent imaging. Imaging is indicated for new focal deficit, persistent altered mental status, trauma, or a change in seizure character.
The AIIE synthesis above is ARKA-authored; the sources below are the underlying external literature.
Annals of Emergency Medicine · 2014doi:10.1016/j.annemergmed.2014.01.018
American College of Radiology · 2024